Frederick G Duffner insider trades: Pacifichealth Laboratories (PHLI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frederick reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 11, 2011 | PHLI | ↑ Buy | 100,000 | $0.25 | $25K | Direct | May 13, 2011 (2d) |
| Mar 22, 2011 | PHLI | ↑ Buy | 100,000 | $0.25 | $25K | Direct | Mar 23, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Frederick G Duffner's insider trades
Frederick G Duffner is President and CEO at Pacifichealth Laboratories (PHLI). Since Mar 22, 2011, Frederick has reported 2 open-market purchases worth $50K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.